We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Mutated Lamin Gene Causes Muscular Dystrophy-Like Muscle Malformation in Worm Model

By LabMedica International staff writers
Posted on 16 Oct 2011
By introducing a mutation in the gene coding for lamin in a roundworm model, researchers have shown that the affected worms experience perturbed body muscle ultrastructure and reduced muscle function similar to that seen in humans suffering from Emery–Dreifuss muscular dystrophy (EDMD).

Most cases of Emery–Dreifuss muscular dystrophy are caused by mutations in the EMD gene. More...
This gene provides instructions for making a protein called emerin, which appears to be essential for the normal function of skeletal and cardiac muscle. Less commonly, Emery–Dreifuss muscular dystrophy results from mutations in the LMNA gene. This gene provides instructions for making two very similar proteins, lamin A and lamin C. Most of the LMNA mutations that cause this condition result in the production of an altered version of these proteins.

To examine how lamin mutations cause EDMD investigators at the Hebrew University of Jerusalem (Israel) and their colleague from the Friedrich Miescher Institute for Biomedical Research (Basel, Switzerland) genetically engineered a population of roundworms (Caenorhabditis elegans) to express at low levels in otherwise wild-type worms a lamin carrying a point mutation, Y59C.

They reported in the September 29, 2011, online edition of the journal Current Biology that the worms carrying the point mutation had abnormal retention of a muscle-specific gene array at the nuclear periphery. This effect was specific to muscle and had no effect on other cells. These animals exhibited selectively perturbed body muscle structure and reduced muscle function, which resembled the situation in human EDMD patients.

Results of this study further showed that at the molecular level lamin was necessary for the perinuclear positioning of heterochromatin. Normal lamin filaments function to position silent genes at the nuclear periphery and allow release of the activated normal gene. Failure to so results in muscular deformation in the worm that is highly reminiscent of human EDMD.

Related Links:
Hebrew University of Jerusalem
Friedrich Miescher Institute for Biomedical Research




Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Real-Time PCR System
Gentier 96T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.